Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 7/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | LPL | P06858 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23097279 | 1.00 | PDK2 (0.35) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL22662401 | 1.00 | PDK2 (0.35) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL24255513 | 0.99 | PDK2 (0.36) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL16801986 | 0.96 | PDK2 (0.39) | PDK2PTGS2 | |
| SCHEMBL16801978 | 0.96 | PDK2 (0.33) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL23939975 | 0.96 | PDK2 (0.39) | PDK2PTGS2 | |
| SCHEMBL24406412 | 0.96 | PDK2 (0.39) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL24255794 | 0.95 | PDK2 (0.35) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL24236184 | 0.94 | PDK2 (0.34) | PDK2PTGS2KDM4EALDH1A1CYP1A2 | |
| SCHEMBL24612822 | 0.94 | PDK2 (0.37) | PDK2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792259-B1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | CHANGCHUN HYPERIONS TECH CO LTD (CN) | 2023-11-29 | — | — | EP | disclosed |
| US-20210078989-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) | 2021-03-18 | — | — | US | disclosed |
| EP-3792259-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | Changchun Hyperions Technology Co., Ltd. (CN) | 2021-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210078989-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | SOX18, TYR, L1CAM | PDK2 1382/4885PTGS2 3043/4885KDM4E 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.